Comparison of clinical data sets acquired on different tomographs using 6-18F-L-dopa

European Journal of Nuclear Medicine

Volumn 27, Issue 6, 2000, Pages 707-712

  Ribeiro, Maria João ^a,b   Remy, Philippe ^a   Bendriem, Bernard ^c   Almeida, Pedro ^a,d   Brulon, Vincent ^a   Samson, Yves ^a   Mazière, Bernard ^a   Trébossen, Régine ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CTI PET Systems Inc   (United States)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

6 18F L dopa; Acquisition modes; Positron emission tomography; Reconstruction protocols

Indexed keywords

CARBIDOPA; FLUORINE 18; LEVODOPA;

ADULT; ARTICLE; CAUDATE NUCLEUS; CELL SURVIVAL; CORPUS STRIATUM; DEGENERATIVE DISEASE; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NERVE CELL; NORMAL HUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PUTAMEN;

ADULT; AGED; CORPUS STRIATUM; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034118506     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050566     Document Type: Article

References (24)

1. 1. Snow BJ, Nygaard TG, Takahashi H, Calbe DB. Positron emission tomographic studies of DOPA-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993; 34: 733-738.
2. 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1990; 28: 547-555.
3. 18F]dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1995; 59: 597-600.
4. 18F-dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996; 119:585-591.
5. 18F]fluoro-dopa uptake in the human striata. J Cereb Blood Flow Metab 1998; 18: 951-959.
6. 6. Adam LE, Zaers J, Ostertag H, Trojan H, Bellemann ME, Brix G. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard. IEEE Trans Nucl Sci 1997; 44: 1172-1179.
7. 7. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5: 584-590.
8. 8. Mazoyer B, Trebossen R, Deutch R, Casey M, Blohm K. Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomograph. IEEE Trans Med Imag 1991; 10: 499-504.
9. 9. Bendriem B, Trébossen R, Frouin V, Lamer O, Brulon V, Syrota A. Evaluation of a PET scanner in 2D and 3D acqusition mode. Proc IEEE Eng Med Biol Soc 1992; 5: 1837-1840.
10. 10. Spinks TJ, Jones T, Bailey DL, Townsend DW, Grootoonk S, Bloomfield PM, Gilardi MC, Casey ME, Sipe B, Reed J. Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 1992; 37: 1637-1655.
11. 11. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38: 1614-1623.
12. 18F]-fluoro-L-dopa in rats, monkeys and humans. Life Sci 1990; 47: 149-157.
13. 13. Bergstrom M, Eriksson L, Bohm C, Blomqvist G, Litton JE. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 1983; 7: 42-50.
14. 14. Kinahan PE, Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE Trans Nucl Sci 1989; 36: 964-968.
15. 15. Kinahan PE, Karp JS. Figures of merit for comparing reconstruction algorithms with a volume-imaging PET scanner. Phys Med Biol 1994; 39: 631-638.
16. 16. Watson CC, Newport D, Casey ME. A single scatter simulation technique for scatter correction in 3D PET. In: 1995 International Meeting on Fully Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine. Aix-les-Bains, Savoie, France. 995;215-219.
17. 17. Karp JS, Daube-Witherspoon ME, Hoffman EJ, Lewellen TK, Links JM, Wong WH, Hichwa RD, Casey ME, Colsher JG, Hitchens RE, Muehllehner G, Stoub EW. Performance standards in positron emission tomography. J Nucl Med 1991; 32: 2342-2350.
18. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995; 38: 580-588.
19. 19. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle GV, Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. Short-and long-term survival and function of unilateral intrastiatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997; 42: 95-107.
20. 20. Bendriem B, Dewey SL, Schlyer DJ, Wolf AP, Volkow ND. Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning. IEEE Trans Med Imag 1991; 10: 216-222.
21. 21. Bailey DL, Jones T, Spinks TJ. A method for measuring the absolute sensitivity of positron emission tomographic scanners. Eur J Nucl Med 1991; 18: 374-379.
22. 22. Bailey DL. Quantification in 3D positron emission tomography. Clinical application of quantitative 3D PET. Surrey: University of Surrey, 1996.
23. 23. Ferreira NC, Trébossen R, Bendriem B. Assessment of 3-D PET quantitation: influence of out of the field of view radioactive sources and attenuating media. IEEE Trans Nucl Med 1998; 3: 1670-1675.
24. 18F-fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med 1992; 33: 1472-1477.